Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02367469 : Tryptophan Metabolism in Human Brain Tumors
PhaseN/A
AgesMin: 13 Years Max: N/A
Eligibility
Inclusion Criteria:

1. Clinical and MRI diagnosis of an intracranial lesion suspicious for a brain tumor,
including primary and metastatic tumors, or a possible residual or recurrent brain
tumor (based on clinical imaging); or history of glioma treatment with chemoradiation,
even if no definite progression is found on clinical MRI.

2. Age ?13 years.

Exclusion Criteria:

1. Severe increased intracranial pressure, status epilepticus, or other symptoms
requiring emergency or urgent intervention.

2. Resective surgery within 2 months prior to the PET scan (acute/subacute post-surgical
inflammatory changes may cause false positive increases on AMT PET).

3. Positive pregnancy test (because of radiation involved in PET scanning).
LinksPermanent Link to THIS page: http://virtualtrials.com/nct/display1trial.cfm?nct=NCT02367469      |      Link to official Clinicaltrials.gov listing
Locations
Detroit, Michigan
Facility: Wayne State University
Investigator: Csaba Juhasz, MD, PhD
Contact: Lynda Ferguson Phone: 313-993-0006
Click HERE to send email to this center




Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites